A/Prof Nicole McCarthy 40 Chasely Street, Auchenflower, Queensland 4066

Welcome to the webpage for A/Prof Nicole McCarthy, located at Chasely Street, Auchenflower, Australia. A/Prof McCarthy is a highly respected doctor and health professional, specializing in medical oncology and internal medicine. She obtained her medical degree from the University of Queensland in 1990 and went on to complete her training in Brisbane, earning her Fellowship of the Royal Australasian College of Physicians in 1998.

In order to further her academic career, A/Prof McCarthy joined the prestigious National Cancer Institute in Bethesda, MD, USA, where she completed a Medical Oncology Fellowship program from 1998 to 2001. During this time, her main focus was on clinical trials and translational research, particularly investigating new drug treatments for breast cancer, including inflammatory breast cancer and anti-angiogenesis agents. She also completed a Masters in Health Sciences in Clinical Research through Duke University, with her thesis concentrating on autologous stem cell transplant and immune reconstitution in patients with metastatic breast cancer.

After spending two years in Auckland, A/Prof McCarthy returned to Brisbane in 2006 and has since dedicated herself to clinical trials research. She currently serves as the Chair of the Breast Cancer Trials Medical Oncology Craft Group and is a member of their Scientific Advisory Committee. Her clinical and research interests extend beyond breast cancer to include the management of gynecological cancers and sarcomas. A/Prof McCarthy is actively involved in several national advisory boards and guideline groups, as well as breast cancer consumer groups such as the Kim Walter’s Choices Program and the Breast Cancer Network of Australia.

A/Prof McCarthy's work has been published in leading journals, and she is an investigator on several grants, including those from the NHMRC and Queensland Cancer Council. Since September 2009, she has held the position of Associate Professor in Medicine at the University of Queensland.

In addition to her impressive academic and research background, A/Prof McCarthy is currently involved in several important clinical trials, including a Phase 1 study of OP-1250 in combination with the CDK4/6 inhibitor Palbociclib for advanced or metastatic HR-positive, HER2-negative breast cancer. She is also participating in an open-label, multinational Phase 3b/4 study of Trastuzumab Deruxtecan for previously treated advanced/metastatic HER2-positive breast cancer, with or without baseline brain metastasis. Furthermore, she is involved in a study focusing on de-escalation adjuvant chemotherapy in HER2 /ER-/Node-neg early breast cancer patients who achieved pCR after neoadjuvant chemotherapy and dual HER2 blockade.

A/Prof Nicole McCarthy is a dedicated and esteemed medical professional, committed to advancing the field of oncology through her clinical work, research, and involvement in clinical trials.